Inspection Record

Zions RX Formulations Services LLC dba Rx Formulation Serv. — FDA 483 Findings

US FDAInspected 2015-07-10Published 2024-01-17 8 findingsContamination controlDeviation, CAPA, and investigationAseptic processing and sterility assuranceStability and storageEquipment and facility

View the regulator's official source The source document is always the basis for judgement.

Findings

1Contamination control

Protective apparel is not worn as necessary to protect drug products from contamination.

2Deviation, CAPA, and investigation

There is a failure to thoroughly review any unexplained discrepancy whether or not the batch has been already distributed.

3Aseptic processing and sterility assurance

Each batch of drug product purporting to be sterile and pyrogen-free is not laboratory tested to determine conformance to such requirements.

4Stability and storage

There is no written testing program designed to assess the stability characteristics of drug products.

5Aseptic processing and sterility assurance

Aseptic processing areas are deficient regarding the system for monitoring environmental conditions.

6Aseptic processing and sterility assurance

Procedures designed to prevent microbiological contamination of drug products purporting to be sterile do not include adequate validation ofthe sterilization process.

7Equipment and facility

Written procedures for cleaning and maintenance fail to include description in sufficient detail of methods, equipment and materials used and description in sufficient detail of the methods of disassembling and reassembling equipment as necessar y to assure proper cleaning and maintenance.

8Aseptic processing and sterility assurance

Procedures designed to prevent microbiological con ination of drug products purporting to be sterile are not established.

About this record

Extracted automatically from the document US FDA published on 2024-01-17. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Zions RX Formulations Services LLC dba Rx Formulation Serv. company profile — full history US FDA documents, 2024 Go to Findings search